Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. HSO

Healthscope Limited (ASX: HSO) - Share Price and Research

DELISTED - Current share price for HSO : $2.460

Intelligent Investor free trial for buy hold sell stock recommendations

HSO General Information +

ASX Code HSO
Website N/A
Industry/Sector Health Care Facilities
Market Cap ($M) n/a
HSO Share Price $2.460
Day High $2.470
Day Low $2.460
Last Close $2.460
HSO Share Price Movement - ( No change )
Prices as at 16:35, 12 Jun 2019
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

HSO Related Research

Healthscope Limited (HSO) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 3.5¢ 100% 4 Mar 2019 26 Mar 2019 $2.460 $2.460 2.85%
HFResult 3.5¢ 0% 6 Sep 2018 28 Sep 2018 $2.460 $2.460 2.85%
Result 3.2¢ 0% 1 Mar 2018 23 Mar 2018 $2.460 $2.460 2.85%

See all dividends from Healthscope Limited (HSO) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Healthscope Limited (HSO) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Removal from Official List 11 Jun 2019 9:49AM $2.460 $2.460 $2.460 fallen by 0%
Implementation of Scheme 6 Jun 2019 2:40PM $2.460 $2.460 $2.460 fallen by 0%
Ceasing to be a substantial holder 3 Jun 2019 8:15AM $2.460 $2.460 $2.460 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Healthscope Limited (HSO) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

HSO Directors

Name Position Start Date
Mr Gordon Ballantyne Chief Executive Officer, Managing Director 16 May 2017
Ms Paula Jane Dwyer Non-Executive Chairman, Non-Executive Director 28 Jun 2014
Mr Rupert H Myer Non-Executive Director 28 Jun 2014
Dr Zygmunt (Ziggy) Edward Switkowski Non-Executive Director 4 Apr 2016
Mr Antoni Michael Cipa Non-Executive Director 28 Jun 2014
Dr Michael Philip Stanford Non-Executive Director 26 Mar 2018
Ms Jane Frances McAloon Non-Executive Director 1 Mar 2016
Mr Paul Dominic O'Sullivan Non-Executive Director 1 Jan 2016

Healthscope Limited (HSO) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
28 Sep 2018 MCALOON, Jane Issued Indirect Shares 1,181 $2.082 $2,459.078
28 Sep 2018 CIPA, Antoni Issued Indirect Shares 1,744 $2.082 $3,631.357
28 Sep 2018 MYER, Rupert Issued Indirect Shares 4,219 $2.082 $8,784.802

See all changes in directors' interest & trades for Healthscope Limited (HSO) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

HSO Management

Name Position
Michael Sammells Chief Financial Officer
Michael Coglin Chief Medical Officer
Ingrid Anne Player General Counsel,Company Secretary
Anoop Singh General Manager International Pathology
Mark Briscoe General Manager Operations
Katherine Paroz Group Executive Human Resources
Ingrid Player Group Executive Legal, Governance & Sustainability
Richard Herman Head of Assurance
Stephen Gameren Hospitals State Manager NSW & ACT
Arthur Yannakou Hospitals State Manager QLD, NT & WA
Alan Lane Hospitals State Manager SA & ACHA Chief Executive Officer
Bronte Kumm Hospitals State Manager VIC & TAS
Cathy Jones National Manager Quality & Compliance

HSO Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (HSO). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
252,643,305 (14.52%) BGH Capital Pty Ltd
176,111,600 (10.10%) NorthWest Healthcare Properties Real Estate Investment Trust
163,142,252 (9.38%) Ellerston Capital Limited and its associates
87,122,354 (5.01%) The Vanguard Group,Inc

FAQs about Healthscope Limited (HSO)

Healthscope Limited's (HSO) current share price is $2.46. This constitutes a price movement of 0% when compared to the share price 7 days ago and is n/a below HSO's 12-month high of n/a per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $2.46, Healthscope Limited's (HSO) current share price of $2.46 constitutes a movement of or 0%. Healthscope Limited's (HSO) share price movement is 0% when compared to 7 days ago and is n/a below HSO's 52-week high of n/a.

Healthscope Limited (HSO) last dividend payment was $0.04 per share and was paid on 26 Mar 2019. This last HSO dividend included 100% franking.

Healthscope Limited (HSO) will release its next Annual Report on n/a. Healthscope Limited's (HSO) last annual report was released on 21 Aug 2018. Click here to view Healthscope Limited's (HSO) last annual report.

Healthscope Limited (HSO) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.